12:00 AM
 | 
Jan 17, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Maxim Pharmaceuticals preclinical data

MMP said that its topical gel reduced the duration and extent of ulcerative lesions in two preclinical studies using a hamster cheek...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >